The Immune Response Corporation Injects First Patient in Trial of ... - PR Newswire (press release)
March 7, 2007| The Immune Response Corporation Injects First Patient in Trial of ... PR Newswire (press release), NY - NeuroVax(TM) may represent a significant advance in the treatment of MS, which affects more than 2.5 million people worldwide, including more than 400000 in ... |
The Winchester Star - Winchester Star
March 7, 2007 Winchester Star | The Winchester Star Winchester Star, VA - Sibert, a resident of Warren County and imaging technician at Winchester Medical Center, shared his story of living with rheumatoid arthritis during the ... |
EntreMed Commences Panzem(R) NCD Phase 2 Clinical Trial In Renal ... - Medical News Today (press release)
March 7, 2007| EntreMed Commences Panzem(R) NCD Phase 2 Clinical Trial In Renal ... Medical News Today (press release), UK - ... cell cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. ... |